Editorial: Advances in radiotherapy for head and neck cancer.
作者信息
Iorio Giuseppe Carlo, Denaro Nerina, Livi Lorenzo, Desideri Isacco, Nardone Valerio, Ricardi Umberto
机构信息
Department of Oncology, Radiation Oncology, University of Turin, Turin, Italy.
Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
出版信息
Front Oncol. 2024 Jun 7;14:1437237. doi: 10.3389/fonc.2024.1437237. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Advances in radiotherapy for head and neck cancer.
Front Oncol. 2024 Jun 7;14:1437237. doi: 10.3389/fonc.2024.1437237. eCollection 2024.
2
App-Controlled Treatment Monitoring and Support for Patients With Head and Neck Cancer Undergoing Radiotherapy: Results From a Prospective Randomized Controlled Trial.
J Med Internet Res. 2023 Oct 19;25:e46189. doi: 10.2196/46189.
3
A proposed framework for the implementation of head and neck cancer treatment at a new cancer center from a radiation oncology perspective.
Asia Pac J Clin Oncol. 2024 Apr;20(2):168-179. doi: 10.1111/ajco.13963. Epub 2023 Apr 26.
4
Results of a survey on elderly head and neck cancer patients on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Acta Otorhinolaryngol Ital. 2020 Dec;40(6):405-409. doi: 10.14639/0392-100X-N0618.
5
Matrix Metalloproteinases and Their Inhibitors as Potential Prognostic Biomarkers in Head and Neck Cancer after Radiotherapy.
Int J Mol Sci. 2023 Dec 30;25(1):527. doi: 10.3390/ijms25010527.
6
An update on radiation therapy in head and neck cancers.
Expert Rev Anticancer Ther. 2018 Apr;18(4):359-364. doi: 10.1080/14737140.2018.1446832. Epub 2018 Mar 1.
7
Supportive care among head and neck cancer patients: An initial validation of the Dutch version of the Performance Status Scale for Head and Neck Cancer (D-PSS-HN).
Int J Lang Commun Disord. 2023 Sep-Oct;58(5):1668-1679. doi: 10.1111/1460-6984.12894. Epub 2023 May 15.
8
Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
BMC Cancer. 2019 Jan 14;19(1):64. doi: 10.1186/s12885-018-5243-3.
9
National and international guidelines on the replacement of missing teeth with dentures for head and neck cancer patients post-radiotherapy: A rapid review.
Saudi Dent J. 2023 Feb;35(2):125-132. doi: 10.1016/j.sdentj.2023.01.009. Epub 2023 Feb 1.
10
Patterns of postoperative radiotherapy for head and neck cancer in Italy: a prospective, observational study by the head and neck group of the Italian Association for Radiation Oncology (AIRO).
Tumori. 2011 Mar-Apr;97(2):170-6. doi: 10.1177/030089161109700207.
引用本文的文献
1
Advancing Head and Neck Cancer Therapies: From Conventional Treatments to Emerging Strategies.
Biomedicines. 2025 Apr 25;13(5):1046. doi: 10.3390/biomedicines13051046.
本文引用的文献
1
Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma.
JAMA Netw Open. 2023 Jan 3;6(1):e2250607. doi: 10.1001/jamanetworkopen.2022.50607.
2
Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial.
Lancet Oncol. 2022 Apr;23(4):479-490. doi: 10.1016/S1470-2045(22)00058-4. Epub 2022 Feb 28.
3
The Impact of Pelvic Nodal Radiotherapy on Hematologic Toxicity: A Systematic Review with Focus on Leukopenia, Lymphopenia and Future Perspectives in Prostate Cancer Treatment.
Crit Rev Oncol Hematol. 2021 Dec;168:103497. doi: 10.1016/j.critrevonc.2021.103497. Epub 2021 Oct 16.
4
A deep learning-based auto-segmentation system for organs-at-risk on whole-body computed tomography images for radiation therapy.
Radiother Oncol. 2021 Jul;160:175-184. doi: 10.1016/j.radonc.2021.04.019. Epub 2021 May 4.
5
Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol. 2021 Mar;22(3):381-390. doi: 10.1016/S1470-2045(20)30673-2. Epub 2021 Feb 15.
6
Decreasing treatment burden in HPV-related OPSCC: A systematic review of clinical trials.
Crit Rev Oncol Hematol. 2021 Apr;160:103243. doi: 10.1016/j.critrevonc.2021.103243. Epub 2021 Jan 29.
7
Radiation-Induced Lymphopenia Beyond the COVID-19 Pandemic.
Front Oncol. 2020 Nov 18;10:617302. doi: 10.3389/fonc.2020.617302. eCollection 2020.
8
Predictors of surgical readmission, unplanned hospitalization and emergency department use in head and neck oncology: A systematic review.
Oral Oncol. 2020 Dec;111:105039. doi: 10.1016/j.oraloncology.2020.105039. Epub 2020 Oct 23.
9
Dosiomics improves prediction of locoregional recurrence for intensity modulated radiotherapy treated head and neck cancer cases.
Oral Oncol. 2020 May;104:104625. doi: 10.1016/j.oraloncology.2020.104625. Epub 2020 Mar 6.
10
Dosiomics: Extracting 3D Spatial Features From Dose Distribution to Predict Incidence of Radiation Pneumonitis.
Front Oncol. 2019 Apr 12;9:269. doi: 10.3389/fonc.2019.00269. eCollection 2019.
Zotero 插件